ODM-104
- Generic Name
- ODM-104
Blood-Brain Barrier Penetration of Therapeutic Agents in Human
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 4
- Registration Number
- NCT04571996
- Locations
- 🇫🇮
CRST Turku, Turku, Finland
Dose-finding Pharmacokinetic Study in Healthy Males
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 56
- Registration Number
- NCT03055936
- Locations
- 🇩🇪
Nuvisan Pharma Services, Neu-Ulm, Germany
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 101
- Registration Number
- NCT01840423
- Locations
- 🇩🇪
Parexel International GmbH, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath